Authors: Steele, JPC O'Doherty, CA Shamash, J Evans, MT Gower, NH Tischkowitz, MD Rudd, RM

Citation: Jpc. Steele et al., Phase II trial of liposomal daunorubicin in malignant pleural mesothelioma, ANN ONCOL, 12(4), 2001, pp. 497-499

Authors: Mulatero, CW Penson, RT Papamichael, D Gower, NH Evans, M Rudd, RM

Citation: Cw. Mulatero et al., A phase II study of combined intravenous and subcutaneous interleukin-2 inmalignant pleural mesothelioma, LUNG CANC, 31(1), 2001, pp. 67-72

Authors: Steele, JPC Shamash, J Evans, MT Gower, NH Tischkowitz, MD Rudd, RM

Citation: Jpc. Steele et al., Phase II study of vinorelbine in patients with malignant pleural mesothelioma, J CL ONCOL, 18(23), 2000, pp. 3912-3917

Authors: Spiro, SG Gower, NH Evans, MT Facchini, FM Rudd, RM

Citation: Sg. Spiro et al., Recruitment of patients with lung cancer into a randomised clinical trial:experience at two centres, THORAX, 55(6), 2000, pp. 463-465

Authors: Cullen, MH Billingham, LJ Woodroffe, CM Chetiyawardana, AD Gower, NH Joshi, R Ferry, DR Rudd, RM Spiro, SG Cook, JE Trask, C Bessell, E Connolly, CK Tobias, J Souhami, RL

Citation: Mh. Cullen et al., Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: Effects on survival and quality of life, J CL ONCOL, 17(10), 1999, pp. 3188-3194